-
Study aim
-
The effects of Na- selenite and Na- selenite -enriched yeast supplementation on glycemic status, lipid profile, oxidative and nitrosative stress in patients with coronary artery diseases
-
Design
-
A clinical trial with a placebo group with parallel, double-blind and Phase 2 randomization based on a table of random sequences on 45 patients
-
Settings and conduct
-
َA double-blind randomized clinical trial study (blinding of patients and investigators)
Setting: Shahid madani heart hospital
-
Participants/Inclusion and exclusion criteria
-
inclusion criteria: Participants with age range 30-65 years old, Diagnosis of atherosclerosis, Not taking any antioxidant and anti-inflammatory supplements, Overweight and obese patients,
Exclusion criteria: Malignancies, autoimmune, and infectious diseases. Blood disease. Chronic diseases, such as liver, kidney, and thyroid diseases. Pregnancy and lactation. Exposure to any side effects during the study. Consumers of antacids, antibiotics, alcohol and cigarette
-
Intervention groups
-
In this project, 45 people with coronary artery disease who refer to the Shahid Madani Hospital in Tabriz, Iran will be selected based on inclusion and exclusion criteria. These patients are randomly divided into three groups of 15 people. The study groups will receive a yeast-enriched yeast capsule with sodium selenite, sodium selenite, or placebo for eight weeks at a daily dose of 200 micrograms before the meal.
-
Main outcome variables
-
Sodium selenium-enriched yeast supplements compared to sodium selenium and placebo supplementation will be more effective on glycemic status; lipid profile; oxidative and nitrosative stress in patients with coronary artery diseases